등록된 논문 166건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG GU10-15비뇨기/부인암

  Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed

  • 저널 Br J Cancer. 2014 May 13;110(10):2472-8
  • 제1저자 이재련
  • 교신저자 이재련

• KCSG BR09-05유방암

  Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).

  • 저널 Ann Oncol. 2013 Jun;24(6):1485-90
  • 제1저자 김혜련, 정경해
  • 교신저자 손주혁

• KCSG LU08-01폐암

  Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial.

  • 저널 Cancer. 2012 Dec 15;118(24):6234-42
  • 제1저자 선종무
  • 교신저자 안명주

• KCSG HN07-01두경부암

  A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01).

  • 저널 Eur J Cancer. 2012 Nov;48(17):3198-204
  • 제1저자 지준호
  • 교신저자 안명주

• KCSG BR07-02유방암

  Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.

  • 저널 J Clin Oncol. 2013 May 10;31(14):1732-9
  • 제1저자 박연희
  • 교신저자 임영혁

• KCSG BR07-01유방암

  Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01.

  • 저널 Breast Cancer Res Treat. 2012 Apr;132(2):589-600
  • 제1저자 임석아
  • 교신저자 노정실

• KCSG HB07-01간담췌암

  A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research

  • 저널 Invest New Drugs . 2012 Jun;30(3):1164-74.
  • 제1저자 오도연
  • 교신저자 방영주

• KCSG CO06-01대장암

  Randomized phase II study of capecitabine with or without oxaliplatin as first-line treatment for elderly or fragile patients with metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group CO06-01.

  • 저널 Am J Clin Oncol . 2013 Dec;36(6):565-71.
  • 제1저자 홍용상
  • 교신저자 김태원

• KCSG CO06-08대장암

  A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group.

  • 저널 Am J Clin Oncol. 2014 Feb;37(1):19-23
  • 제1저자 홍용상
  • 교신저자 김태원

• KCSG ST06-13위암

  Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.

  • 저널 Br J Cancer. 2009 Jan 27;100(2):298-304.
  • 제1저자 한세원
  • 교신저자 김태유

1112131415